Increased shunt through the patent ductus arteriosus after surfactant replacement therapy

https://doi.org/10.1016/S0022-3476(82)80247-3Get rights and content

Instillation of surfactant into the trachea of preterm infants with respiratory distress syndrome is associated with a 90% incidence of patent ductus arteriosus. We studied the effects of surfactant therapy on the ductus arteriosus in 12 preterm lambs. Flow across the ductus arteriosus and systemic blood flow were calculated from radioactive microsphere injections. All developed respiratory failure (pH<7.1, PaCO2>60) by 30 minutes after birth. Between 30 and 60 minutes after birth, six lambs were treated with tracheal instillation of 50 mg/kg surfactant lipid. By two hours after birth, treated lambs differed significantly from controls in pH (7.27±0.02 vs 6.97±0.08) and PaCO2 (43.3±4.1 vs 85±15). There were no differences in PaO2 or PGE2 concentrations or ductus arteriosus resistance, but there was a significantly larger shunt through the ductus arteriosus in treated lambs. This increased shunt resulted from the significant drop in pulmonary vascular resistance and not from a change in patency of the ductus arteriosus. Surfactant replacement may require interventions directed specifically at the patent ductus arteriosus in sick preterm infants.

References (19)

There are more references available in the full text version of this article.

Cited by (95)

  • Patent Ductus Arteriosus in the Preterm Infant

    2023, Avery's Diseases of the Newborn
  • Patent ductus arteriosus in preterm newborns: A tertiary hospital experience

    2022, Revista Portuguesa de Cardiologia
    Citation Excerpt :

    Hyaline membrane disease not only increases the incidence of PDA in preterm infants but has also been associated with the efficacy of response to treatment of PDA with COX inhibitors.28 Additionally, surfactant administration causes a rapid decrease in pulmonary vascular resistance, contributing to increased left-to-right flow through the ductus arteriosus.29 However, in the present study we observed the presence of hyaline membrane disease in 90.1% of the sample, and surfactant was used in 84% of the preterm infants included in the study, making it difficult to assign an association for these variables.

  • Differential determinants of patent ductus arteriosus closure for prematurity of varying birth body weight: A Retrospective Cohort Study

    2020, Pediatrics and Neonatology
    Citation Excerpt :

    Clyman et al. proposed that increased circulating level of prostaglandin E associated with respiratory distress syndrome might contribute to the patency of ductus arteriosus.22 Increased ductal shunting after surfactant administration was reported.23 Our study result highlighted the independent role of surfactant on PDA closure.

  • Patent ductus arteriosus, its treatments, and the risks of pulmonary morbidity

    2018, Seminars in Perinatology
    Citation Excerpt :

    In preterm newborns, the decreased ability to maintain active precapillary pulmonary arterial tone7 allows the intravascular hydraulic pressure to distribute more of its force towards the downstream capillary fluid filtration sites.3 Anything that decreases precapillary tone (e.g., intrauterine growth restriction8 or surfactant administration9–11) can exacerbate the amount of left-to-right shunt, alter the distribution of pulmonary hydraulic pressures to downstream filtration sites, and lead to earlier pulmonary edema and pulmonary hemorrhage.8,11,12 Conversely, therapies that increase precapillary vasoconstriction (e.g., dopamine13) or precapillary resistance (e.g., red blood cell transfusions and increased blood viscosity14) can decrease the left-to-right PDA shunt and redistribute the pressure head upstream, away from the capillary bed.

  • Acute Effects and Long-Term Consequences

    2018, The Newborn Lung: Neonatology Questions and Controversies, Third Edition
View all citing articles on Scopus

Supported by grants from the United States Public Health Service, Program Project Grants HL24056, HD12714, and HL 27356.

View full text